| Next 10 |
Ad
AVTX Articles Avalo Therapeutics Inc.
home / stock / avtx / avtx articles
Articles | Avalo Therapeutics Inc. (NASDAQ:AVTX)
-
WAYNE, Pa. and ROCKVILLE, Md., July 16, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (NASDAQ:AVTX) today announced that Mittie Doyle, MD, F...
-
WAYNE, Pa. and ROCKVILLE, Md., June 24, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (NASDAQ:AVTX) today announced that Paul Varki has join...
-
WAYNE, Pa. and ROCKVILLE, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (NASDAQ:AVTX) announced today that Garry A. Neil, M.D....
-
Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss. Stryve Foods post...
-
Shares of VirTra, Inc. (NASDAQ: VTSI) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quar...
-
Appointments include industry veterans Aaron Kantoff, Jonathan Goldman, and Samantha Truex as Independent Directors Board of Director appointment...
-
Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG...
-
Acquired AVTX-009, Phase-2 ready anti-IL-1? mAb, in March 2024 Increased cash position with private placement financing in March 2024 providing ...
-
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 15 points on Thursday. The Dow traded up 0.06% to 39,7...
Stock Information
Get AVTX Alerts
News, Short Squeeze, Breakout and More Instantly...
Avalo Therapeutics Inc. Company Name:
AVTX Stock Symbol:
NASDAQ Market:
-3.66% G/L:
$3.95 Last:
20,351 Volume:
$3.98 Open:
$4.10 Close:
Avalo Therapeutics Inc. Website:
Ad
-
2025-05-11 18:48:14 ET Avalo Therapeutics, Inc. (AVTX) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 6.99%. The average open to low on the day of earnings was -7.34%. The average open ...
-
2025-05-11 18:43:14 ET Avalo Therapeutics, Inc. (AVTX) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in AVTX stock price following earnings has averaged ±2.62% , with a median of 1.88%....
-
WAYNE, Pa. and ROCKVILLE, Md., April 30, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced that Dr. Garry Neil, Chief Executive Officer of Avalo, will present at the Citizens L...